LETTER

Hippokratia 2017, 21, 1: 60

Athanasiadis A1,2, Petrakis P1, Mikos T1
1
1st Department of Obstetrics and Gynecology, Papageorgiou General Hospital, Aristotle University of Thessaloniki, 2 Prenatal Diagnosis Center of Thessaloniki, Thessaloniki, Greece

 

Read PDF

Key words: Amniocentesis, perinatal outcome, fetal loss rate, needle caliber, needle size

Corresponding author: Apostolos P. Athanasiadis, Professor in Obstetrics and Gynecology, Aristotle University of Thessaloniki, Ag.Sofias 15 Str, 54623, Thessaloniki, Greece, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Dear Editor,

Genetic amniocentesis was introduced in prenatal diagnosis for chromosomal abnormalities more than 40 years ago1. The most important risk for amniocentesis is the procedure-related miscarriage (0.11-1.00 %)2. Regarding the size of the needle used in amniocentesis, recent data showed that the 20G larger-caliber needle performs better because the duration of the procedure is significantly shorter and the placental bleeding at transplacental passages occurs less frequently3.

We conducted a retrospective, single center, comparative study in order to compare fetal loss rate and perinatal outcome after 2nd-trimester amniocentesis performed with 20G and 22G needles (Scientific Bioethical Committee of Aristotle University of Thessaloniki, Greece: A13748/31-8-2010). The study population consisted of all consecutive women who underwent amniocentesis in a single perinatal unit (Center for Prenatal Control, Thessaloniki, Greece) from 2000 to 2006. Women with multifetal pregnancies and fetuses with abnormalities were excluded. All amniocenteses were performed by a single operator (first author). The procedure was performed with either 20G or 22G needle of the same type and manufacturer (SFM GmBH 20GX31/2 inch or 0.90 x 90mm and SFM GmBH 22GX31/2 inch or 0.70 x 90mm; in group A, 22G needles were used from 2000-2003 and in group B, 20G needles from 2003-2006). Perinatal outcome (pregnancy loss, time of loss, premature delivery, time of premature delivery, term delivery, fetal weight at delivery, fetal sex, and mode of delivery) was followed up. Statistics were processed with the Statistical Package for the Social Sciences (SPSS), version 17.00 (SPSS Inc., Chicago, IL, USA).  In total, 3,054 women were studied: 1,519 in group A and 1,535 in group B; valid data existed for 2,718 women: 1,329 (group A) and 1,390 (group B).  The results are summarized in Table 1. A multiple logistic regression analysis was performed to examine the relationship of the type of the needle with the fetal loss before 24 weeks of gestation, after controlling for demographic and clinical variables. After adjustment of clinical and demographic parameters, no statistical difference between the two needle groups was found in relation to fetal loss before 24 weeks. However, we have to consider as limitations of the study that gravidity and 1st trimester bleeding were variables associated with increased likelihood of fetal loss.

In conclusion, this study confirms that amniocentesis with a 20G needle appears to have similar fetal loss rates compared with a 22G needle.

Conflict of interest

Authors report no conflicts of interest.

References

1. Steele MW, Breg WR Jr. Chromosome analysis of human amniotic-fluid cells. Lancet. 1966; 1: 383-385.
2. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D’Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015; 45: 16-26.
3. Athanasiadis AP, Pantazis K, Goulis DG, Chatzigeorgiou K, Vaitsi V, Assimakopoulos E, et al. Comparison between 20G and 22G needle for second trimester amniocentesis in terms of technical aspects and short-term complications. Prenat Diagn. 2009; 29: 761-765.